Skip to content

Clinical trials

Terminated Phase 4 Multiple Sclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 4 Status: Terminated Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20072
20081
20092
20101
20113
20131
20141
20153
20163
20171
20212
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Biogen2
University Hospital, Strasbourg, France2
Weill Medical College of Cornell University2
Brigitte Schürch1
Carmel Medical Center1
Claudio Gobbi1
EMD Serono1
Elliot Frohman1
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis25
Multiple Sclerosis, Relapsing-Remitting4
COVID-191
Chronic Pain1
Cognitive Dysfunction1
Coronavirus Infections1
Erythema1
Fatigue1
Multiple Sclerosis, Chronic Progressive1
Nerve Degeneration1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.